Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota
- PMID: 31747557
- DOI: 10.1016/j.phrs.2019.104552
Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota
Abstract
In recent years, although the concept and means of modern treatment of chronic heart failure(CHF) are continually improving, the readmission rate and mortality rate are still high. At present, there is evidence that there is a link between gut microbiota and heart failure, so the intervention of gut microbiota and its metabolites is expected to become a potential new therapeutic target in heart failure. Traditional Chinese medicine(TCM) has apparent advantages in stabilizing the disease, improving heart function, and improving the quality of life. It can exert its effect by operating in the gut microbiota and is an ideal intestinal micro-ecological regulator. Therefore, this article will mainly discuss the advantages of traditional Chinese medicine in treating CHF, the relationship between traditional Chinese medicine and gut microbiota, the relationship between CHF and gut microbiota, and the ways of regulating gut microbiota by traditional Chinese medicine to prevent and treat CHF. It will specify the target and mechanism of traditional Chinese medicine treating heart failure by acting gut microbiota and provide ideas for the treatment of heart failure.
Keywords: Chronic heart failure; Gut Microbiota; Traditional Chinese medicine; Treatment.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure.Phytomedicine. 2023 Aug;117:154885. doi: 10.1016/j.phymed.2023.154885. Epub 2023 May 22. Phytomedicine. 2023. PMID: 37302262 Review.
-
Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.Pharmacol Res. 2019 Oct;148:104453. doi: 10.1016/j.phrs.2019.104453. Epub 2019 Sep 18. Pharmacol Res. 2019. PMID: 31541688 Review.
-
The Gut Microbiota and Traditional Chinese Medicine: A New Clinical Frontier on Cancer.Curr Drug Targets. 2021;22(11):1222-1231. doi: 10.2174/1389450122666210412141304. Curr Drug Targets. 2021. PMID: 33845736 Review.
-
Gut microbiota: A new target of traditional Chinese medicine for insomnia.Biomed Pharmacother. 2023 Apr;160:114344. doi: 10.1016/j.biopha.2023.114344. Epub 2023 Feb 2. Biomed Pharmacother. 2023. PMID: 36738504 Review.
-
The cardiac protection of Baoyuan decoction via gut-heart axis metabolic pathway.Phytomedicine. 2020 Dec;79:153322. doi: 10.1016/j.phymed.2020.153322. Epub 2020 Sep 2. Phytomedicine. 2020. PMID: 32920286
Cited by
-
Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms.Front Endocrinol (Lausanne). 2024 Sep 30;15:1366285. doi: 10.3389/fendo.2024.1366285. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39403576 Free PMC article. Review.
-
The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial.Nat Med. 2024 Aug;30(8):2295-2302. doi: 10.1038/s41591-024-03169-2. Epub 2024 Aug 2. Nat Med. 2024. PMID: 39095596 Free PMC article. Clinical Trial.
-
The role of the gut microbiota in health and cardiovascular diseases.Mol Biomed. 2022 Oct 11;3(1):30. doi: 10.1186/s43556-022-00091-2. Mol Biomed. 2022. PMID: 36219347 Free PMC article. Review.
-
Effects of moxibustion at bilateral Feishu (BL13) and Xinshu (BL15) combined with benazepril on myocardial cells apoptosis index and apoptosis-related proteins cytochrome c and apoptosis-inducing factor in rats with chronic heart failure.J Tradit Chin Med. 2022 Apr;42(2):227-233. doi: 10.19852/j.cnki.jtcm.20220126.001. J Tradit Chin Med. 2022. PMID: 35473343 Free PMC article.
-
Chinese traditional medicine DZGP beneficially affects gut microbiome, serum metabolites and recovery from rheumatoid arthritis through mediating NF-κB signaling pathway.Heliyon. 2024 Jun 26;10(13):e33706. doi: 10.1016/j.heliyon.2024.e33706. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39071566 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical